BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 28886017)

  • 1. B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis.
    Moura RA; Quaresma C; Vieira AR; Gonçalves MJ; Polido-Pereira J; Romão VC; Martins N; Canhão H; Fonseca JE
    PLoS One; 2017; 12(9):e0182927. PubMed ID: 28886017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Cytokine Inhibition Modulates Activation and Homing Receptors of Peripheral Memory B Cell Subsets in Rheumatoid Arthritis Patients.
    Mahmood Z; Schmalzing M; Dörner T; Tony HP; Muhammad K
    Front Immunol; 2020; 11():572475. PubMed ID: 33042152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis.
    Sellam J; Rouanet S; Hendel-Chavez H; Abbed K; Sibilia J; Tebib J; Le Loët X; Combe B; Dougados M; Mariette X; Taoufik Y
    Arthritis Rheum; 2011 Dec; 63(12):3692-701. PubMed ID: 22127692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factor.
    Souto-Carneiro MM; Mahadevan V; Takada K; Fritsch-Stork R; Nanki T; Brown M; Fleisher TA; Wilson M; Goldbach-Mansky R; Lipsky PE
    Arthritis Res Ther; 2009; 11(3):R84. PubMed ID: 19500335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis.
    Mahmood Z; Muhammad K; Schmalzing M; Roll P; Dörner T; Tony HP
    Arthritis Res Ther; 2015 Mar; 17(1):61. PubMed ID: 25888920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status.
    Michelutti A; Gremese E; Morassi F; Petricca L; Arena V; Tolusso B; Alivernini S; Peluso G; Bosello SL; Ferraccioli G
    Mol Med; 2011; 17(9-10):901-9. PubMed ID: 21607290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis.
    Fedele AL; Tolusso B; Gremese E; Bosello SL; Carbonella A; Canestri S; Ferraccioli G
    BMC Immunol; 2014 Sep; 15():28. PubMed ID: 25187226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment.
    Cambridge G; Perry HC; Nogueira L; Serre G; Parsons HM; De La Torre I; Dickson MC; Leandro MJ; Edwards JC
    J Autoimmun; 2014 May; 50():67-76. PubMed ID: 24365380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RF positivity has substantial influence on the peripheral memory B-cell compartment and its modulation by TNF inhibition.
    Roll P; Muhammad K; Schumann M; Kleinert S; Tony HP
    Scand J Rheumatol; 2012 May; 41(3):180-5. PubMed ID: 22400711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B-cell-activating factor receptor expression on naive and memory B cells: relationship with relapse in patients with rheumatoid arthritis following B-cell depletion therapy.
    de la Torre I; Moura RA; Leandro MJ; Edwards J; Cambridge G
    Ann Rheum Dis; 2010 Dec; 69(12):2181-8. PubMed ID: 20581016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells.
    Muhammad K; Roll P; Seibold T; Kleinert S; Einsele H; Dörner T; Tony HP
    Ann Rheum Dis; 2011 Aug; 70(8):1507-10. PubMed ID: 21551509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [THE IDENTIFICATION OF SUB-POPULATIONS OF B-LYMPHOCYTES OF PERIPHERAL BLOOD USING TECHNIQUE OF FLOW CYTOFLUOROMETRY IN HEALTHY INDIVIDUALS AND PATIENTS WITH RHEUMATOID DISEASES].
    Suponitskaia EV; Aleksankin AP; Aleksandrova EN; Avdeeva AS; Panafidina TA; Verijnikova JG; Nasonov EL
    Klin Lab Diagn; 2015 Jun; 60(6):30-3. PubMed ID: 26466448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis.
    Rehnberg M; Amu S; Tarkowski A; Bokarewa MI; Brisslert M
    Arthritis Res Ther; 2009; 11(4):R123. PubMed ID: 19686595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis.
    Sellam J; Rouanet S; Hendel-Chavez H; Miceli-Richard C; Combe B; Sibilia J; Le Loët X; Tebib J; Jourdan R; Dougados M; Taoufik Y; Mariette X
    Arthritis Rheum; 2013 Sep; 65(9):2253-61. PubMed ID: 23740460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor.
    Kobie JJ; Zheng B; Bryk P; Barnes M; Ritchlin CT; Tabechian DA; Anandarajah AP; Looney RJ; Thiele RG; Anolik JH; Coca A; Wei C; Rosenberg AF; Feng C; Treanor JJ; Lee FE; Sanz I
    Arthritis Res Ther; 2011; 13(6):R209. PubMed ID: 22177419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Derailed B cell homeostasis in patients with mixed connective tissue disease.
    Hajas A; Barath S; Szodoray P; Nakken B; Gogolak P; Szekanecz Z; Zold E; Zeher M; Szegedi G; Bodolay E
    Hum Immunol; 2013 Jul; 74(7):833-41. PubMed ID: 23608739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis.
    Wang J; Shan Y; Jiang Z; Feng J; Li C; Ma L; Jiang Y
    Clin Exp Immunol; 2013 Nov; 174(2):212-20. PubMed ID: 23786438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome.
    Bohnhorst JØ; Bjørgan MB; Thoen JE; Natvig JB; Thompson KM
    J Immunol; 2001 Oct; 167(7):3610-8. PubMed ID: 11564773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool.
    Amu S; Tarkowski A; Dörner T; Bokarewa M; Brisslert M
    Scand J Immunol; 2007 Jul; 66(1):77-86. PubMed ID: 17587349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Antigen-presenting B Cell Phenotypes from Synovial Microenvironment of Patients with Rheumatoid and Psoriatic Arthritis.
    Armas-González E; Díaz-Martín A; Domínguez-Luis MJ; Arce-Franco MT; Herrera-García A; Hernández-Hernández MV; Bustabad S; Usategui A; Pablos JL; Cañete JD; Díaz-González F
    J Rheumatol; 2015 Oct; 42(10):1825-34. PubMed ID: 26178284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.